jme.bmj13d
Assessing the performance of ChatGPT in medical ethical decision-making: a comparative study with USMLE-based scenarios
Introduction The integration of artificial intelligence (AI) into healthcare introduces innovative possibilities but raises ethical, legal and professional concerns. Assessing the performance of AI in ...
jme.bmj14d
The Ethics of Ozempic and Wegovy
Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market. Manufactured by Novo Nordisk, semaglutide is the newest in a family of glucagon ...
jme.bmj7d
How (not) to define ‘assisted dying’
In the last 20 years ‘assisted dying’ (and/or its variants ‘assisted death’, ‘assistance in dying’, ‘aid in dying’) has become increasingly prevalent as a term to denote the intentional ending of the ...
jme.bmj9d
Generational smoking bans: inegalitarian without disadvantage?
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
jme.bmj3d
The unnaturalistic fallacy: COVID-19 vaccine mandates should not discriminate against natural immunity
COVID-19 vaccine requirements have generated significant debate. Here, we argue that, on the evidence available, such policies should have recognised proof of natural immunity as a sufficient basis ...
jme.bmj2d
Beyond regulatory approaches to ethics: making space for ethical preparedness in healthcare research
Correspondence to Dr Kate Lyle, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK; kate.lyle{at}well.ox.ac.uk Centralised, compliance-focused approaches to research ethics have been ...
jme.bmj20y
Gaps, conflicts, and consensus in the ethics statements of professional associations, medical groups, and health plans
Background: Patients today interact with physicians, physician groups, and health plans, each of which may follow distinct ethical guidelines. Method: We systematically compared physician codes of ...
jme.bmj4d
Narrowing the gap: access to HIV treatments in developing countries. A pharmaceutical company's perspective
The advent of new antiretroviral medicines means that the effects of HIV can now be curbed, but only one in twenty infected people have so far benefited. For those living in developing countries, the ...
jme.bmj4d
Dissenting from care.data: an analysis of opt-out forms
Centre for Health Innovation, Leadership and Learning (CHILL), Business School, Nottingham University, Nottingham, UK Correspondence to Dr Paraskevas Vezyridis, Centre for Health Innovation, ...
jme.bmj1d
The first survey of attitudes of medical students in Ireland towards termination of pregnancy
Background Since the UK Abortion Act (1967), women have travelled from Ireland to the UK for legal abortion. In 2011 >4000 women did so. Knowledge and attitudes of medical students towards abortion ...
jme.bmj3d
Which values are important for patients during involuntary treatment? A qualitative study with psychiatric inpatients
Involuntary hospital treatment is practised throughout the world. Providing appropriate treatment in this context is particularly challenging for mental health professionals, who frequently face ...